<VariationArchive RecordType="classified" VariationID="1727001" VariationName="NM_170606.3(KMT2C):c.1759_1769del (p.Gln587fs)" VariationType="Deletion" Accession="VCV001727001" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-05-27" DateCreated="2023-05-20" MostRecentSubmission="2023-05-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1784527" VariationID="1727001">
      <GeneList>
        <Gene Symbol="KMT2C" FullName="lysine methyltransferase 2C" GeneID="58508" HGNC_ID="HGNC:13726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152134925" stop="152436003" display_start="152134925" display_stop="152436003" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151832009" stop="152133089" display_start="151832009" display_stop="152133089" Strand="-" />
          </Location>
          <OMIM>606833</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_170606.3(KMT2C):c.1759_1769del (p.Gln587fs)</Name>
      <CanonicalSPDI>NC_000007.14:152249919:CTCTTCTGTTGCTCTTC:CTCTTC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152249920" stop="152249930" display_start="152249920" display_stop="152249930" variantLength="11" positionVCF="152249919" referenceAlleleVCF="ACTCTTCTGTTG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151947005" stop="151947015" display_start="151947005" display_stop="151947015" variantLength="11" positionVCF="151947004" referenceAlleleVCF="ACTCTTCTGTTG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Q587fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.1759_1769del" MANESelect="true">
            <Expression>NM_170606.3:c.1759_1769del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733751.2" sequenceAccession="NP_733751" sequenceVersion="2" change="p.Gln587fs">
            <Expression>NP_733751.2:p.Gln587fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.151947011_151947021del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.151947011_151947021del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.152249926_152249936del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.152249926_152249936del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033948.1" sequenceAccession="NG_033948" sequenceVersion="1" change="g.191076_191086del">
            <Expression>NG_033948.1:g.191076_191086del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_170606.3(KMT2C):c.1759_1769del (p.Gln587fs) AND Kleefstra syndrome 2" Accession="RCV003228066" Version="1">
        <ClassifiedConditionList TraitSetID="39647">
          <ClassifiedCondition DB="MedGen" ID="C4540395">Kleefstra syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-05-20" MostRecentSubmission="2023-05-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22726846</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29069077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29276005</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33619735</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39647" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38345" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 2</ElementValue>
                <XRef ID="MONDO:0054701" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KLEFS2</ElementValue>
                <XRef Type="MIM" ID="617768" DB="OMIM" />
              </Symbol>
              <XRef ID="C4540395" DB="MedGen" />
              <XRef ID="MONDO:0054701" DB="MONDO" />
              <XRef Type="MIM" ID="617768" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5086316" SubmissionDate="2022-11-16" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="SUB12289968" submittedAssembly="GRCh37" title="SUB12289968" />
        <ClinVarAccession Accession="SCV002601604" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="Applied Translational Genetics Group, University of Auckland" OrgID="506120" OrganizationCategory="other" OrgAbbreviation="ATG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">29276005</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">22726846</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">29069077</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">33619735</ID>
          </Citation>
          <Comment>The p.Gln587SerfsTer7 variant result in early termination of the KMT2C protein. To date, this is the 2nd most 5' nonsense mutation reported, and critically the enzymatically active SET domain has been abolished. Truncating mutations in this gene result in Kleefstra Syndrome 2, a neurodevelopmental disorder presenting with intellectual disability, delayed growth, mild dysmorphic features, and neuropsychiatric traits.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>NZ European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2C">
              <Name>lysine methyltransferase 2C</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_170606.2:exon 13</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_170606.2:c.1759_1769del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617768" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12289968</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5086316" TraitType="Disease" MappingType="XRef" MappingValue="617768" MappingRef="OMIM">
        <MedGen CUI="C4540395" Name="Kleefstra syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

